Find latest Non-Small Cell Lung Cancer videos
·
500+ videos
Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time -0:00
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
10 seconds
Playback speed
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
ASCO® 2024 Insights: "CHRYSALIS-2 Trial - Amivantamab + Lazertinib in Atypical EGFRm Advanced NSCLC"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Byoung Chul Cho
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Byoung Chul Cho
67 views
June 14, 2024
Chapters
CHRYSALIS-2 Trial Overview & Patient Demographics
00:00
Efficacy & Safety of Amivantamab + Lazertinib
03:00
Comparative Analysis & Final Conclusions
05:47
Comments 0
Login to view comments.
Click here to Login